Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
capabilities, and particularly the Experimental Medicine Clinical Research Facility (EMCRF) (https://www.kennedy.ox.ac.uk/news/oxford-and-gsk-launch-experimental-medicine-collaboration). This will allow testing
-
Qualifications Essential Qualifications: PhD degree in Neuroscience, Physics, Electrical Engineering or other related field. At least 4 years hands-on experience in an EM laboratory Ability to organize and execute
-
: https://resources.uta.edu/hr/services/records/compensation-tools.php CBC Requirement It is the policy of The University of Texas at Arlington to conduct a criminal background check on any applicant who is
-
23 Feb 2026 Job Information Organisation/Company University of Nova Gorica Department Human Resources Research Field Physics » Other Researcher Profile Recognised Researcher (R2) Positions PhD
-
algorithms will be assessed for neurodegeneration mapping in Alzheimer’s disease brain organoids. In parallel, the technology and algorithms will be applied to fish health research, supporting studies on ulcer
-
systems based on massively parallel hardware architectures Combination of programmable logic, tensor processors and general-purpose CPUs for real-time adaption and scheduling services (e.g., AMD Versal
-
expanding its focus to space-based missions. We are contributing to the High Energy cosmic-Radiation Detection (HERD) experiment, a next-generation detector for the Chinese Space Station. In parallel, we
-
Identifying novel regulators of colorectal cancer invasion School of Biosciences PhD Research Project Self Funded Dr Kyra Campbell Application Deadline: Applications accepted all year round Details
-
/or peer-reviewed journals Required Knowledge, Skills, and Abilities: PhD in Computational Physics, Chemistry, Materials Science, Computer Science/Engineering, Applied Mathematics, or a related field
-
advanced genome-editing tools. In parallel, we develop in-house sequencing technologies to dissect epigenetic and epitranscriptomic modifications at the molecular level, along with high-throughput platforms